Lenkeit Annika, Oppong Marvin Darkwah, Dinger Thiemo Florin, Gümüs Meltem, Rauschenbach Laurèl, Chihi Mehdi, Ahmadipour Yahya, Uerschels Anne-Kathrin, Dammann Philipp, Deuschl Cornelius, Wrede Karsten H, Sure Ulrich, Jabbarli Ramazan
Department of Neurosurgery and Spine Surgery, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
Acta Neurochir (Wien). 2024 Feb 20;166(1):93. doi: 10.1007/s00701-024-05968-5.
Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating diagnosis. A poor outcome is known to be highly dependent on the initial neurological status. Our goal was to identify other parameters that favor the risk of complications and poor outcome in patients with aSAH and initially favorable neurologic status.
Consecutive aSAH cases treated at our hospital between 01/2003 and 06/2016 with the initial World Federation of Neurosurgical Societies grades I-III were included. Data on demographic characteristics, previous medical history, initial aSAH severity, and functional outcome after aSAH were collected. The study endpoints were the occurrence of cerebral infarcts, in-hospital mortality, and unfavorable outcome at 6 months after aSAH (modified Rankin scale > 3).
In the final cohort (n= 582), the rate of cerebral infarction, in-hospital mortality, and unfavorable outcome was 35.1%, 8.1%, and 17.6% respectively. The risk of cerebral infarction was independently related to the presence of acute hydrocephalus (adjusted odds ratio [aOR]=2.33, p<0.0001), aneurysm clipping (aOR=1.78, p=0.003), and use of calcium channel blockers concomitant to nimodipine (aOR=2.63, p=0.002). Patients' age (>55 years, aOR=4.24, p<0.0001), acute hydrocephalus (aOR=2.43, p=0.036), and clipping (aOR=2.86, p=0.001) predicted in-hospital mortality. Baseline characteristics associated with unfavorable outcome at 6 months were age (aOR=2.77, p=<0.0001), Fisher grades III-IV (aOR=2.81, p=0.016), acute hydrocephalus (aOR=2.22, p=0.012), clipping (aOR=3.98, p<0.0001), admission C-reactive protein>1mg/dL (aOR=1.76, p=0.035), and treatment intervals (aOR=0.64 per-5-year-intervals, p=0.006).
Although cerebral infarction is a common complication in aSAH individuals with favorable initial clinical condition, >80% of these patients show favorable long-term outcome. The knowledge of outcome-relevant baseline characteristics might help to reduce the burden of further complications and poor outcome in aSAH patients who tolerated the initial bleeding event well.
动脉瘤性蛛网膜下腔出血(aSAH)仍然是一种具有毁灭性的诊断。已知不良预后高度依赖于初始神经状态。我们的目标是确定其他因素,这些因素有利于aSAH且初始神经状态良好的患者发生并发症和出现不良预后的风险。
纳入2003年1月至2016年6月在我院接受治疗的连续aSAH病例,初始世界神经外科联合会分级为I - III级。收集人口统计学特征、既往病史、初始aSAH严重程度以及aSAH后功能结局的数据。研究终点为aSAH后6个月时脑梗死的发生、住院死亡率以及不良结局(改良Rankin量表>3)。
在最终队列(n = 582)中,脑梗死发生率、住院死亡率和不良结局发生率分别为35.1%、8.1%和17.6%。脑梗死风险与急性脑积水的存在(调整优势比[aOR]=2.33,p<0.0001)、动脉瘤夹闭(aOR=1.78,p=0.003)以及与尼莫地平同时使用钙通道阻滞剂(aOR=2.63,p=0.002)独立相关。患者年龄(>55岁,aOR=4.24,p<0.0001)、急性脑积水(aOR=2.43,p=0.036)和夹闭(aOR=2.86,p=0.001)可预测住院死亡率。与6个月时不良结局相关的基线特征为年龄(aOR=2.77,p=<0.0001)、Fisher分级III - IV级(aOR=2.81,p=0.016)、急性脑积水(aOR=2.22,p=0.012)、夹闭(aOR=3.98,p<0.0001)、入院时C反应蛋白>1mg/dL(aOR=1.76,p=0.035)以及治疗间隔(每5年间隔aOR=0.64,p=0.006)。
尽管脑梗死是初始临床状况良好的aSAH患者的常见并发症,但这些患者中超过80%显示出良好的长期结局。了解与结局相关的基线特征可能有助于减轻初始出血事件耐受性良好的aSAH患者进一步并发症和不良结局的负担。